Barclays PLC Pep Gen Inc. Transaction History
Barclays PLC
- $327 Billion
- Q2 2024
A detailed history of Barclays PLC transactions in Pep Gen Inc. stock. As of the latest transaction made, Barclays PLC holds 5,248 shares of PEPG stock, worth $46,182. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,248
Previous 7,003
25.06%
Holding current value
$46,182
Previous $103,000
19.42%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding PEPG
# of Institutions
59Shares Held
24.7MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA10.7MShares$94.1 Million2.57% of portfolio
-
Suvretta Capital Management, LLC New York, NY1.52MShares$13.4 Million1.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.5MShares$13.2 Million1.41% of portfolio
-
Viking Global Investors LP1.48MShares$13 Million0.09% of portfolio
-
Perceptive Advisors LLC New York, NY1.41MShares$12.4 Million0.65% of portfolio
About PepGen Inc.
- Ticker PEPG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,631,900
- Market Cap $208M
- Description
- PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...